FDA Launches Expedited IND Pilot Program to Accelerate U.S. Drug Development and Counter Overseas Shift
admin The U.S. Food and Drug Administration (FDA) formally inaugurated its "Expedited Investigational New Drug (IND)...
admin
Biopharma Briefing: Curium’s Generic Radioligand Breakthrough, Novo’s Rebrand Amid Market Shifts, and Pivotal Pipeline Updates Across the Industry
The biopharmaceutical sector witnessed a dynamic week, marked by a landmark regulatory approval, significant corporate...
CureSearch for Childrens Cancer Announces 2026 Community Impact Awards to Advance Psychosocial Support and Holistic Pediatric Oncology Care
CureSearch for Children’s Cancer, a national non-profit organization dedicated to accelerating the development of pediatric...
World Conference on Lung Cancer Highlights Advancements in Targeted Therapies, ADC Innovations, and Global Trial Scrutiny
The annual World Conference on Lung Cancer (WCLC) served as a pivotal forum for the...
Lauren Kate A Nine Year Old Warrior Navigating the Dual Challenges of Down Syndrome and B-Cell Acute Lymphoblastic Leukemia
The intersection of chromosomal conditions and pediatric oncology presents a complex medical journey for families,...
Pioneering Research Illuminates Fertility Considerations for Blood Cancer Survivors Undergoing CAR T-Cell Therapy
The landscape of cancer treatment is continually evolving, offering renewed hope for patients facing once-incurable...
Second Annual Walk by Faith Gala Raises Over One Hundred Thousand Dollars to Support Childhood Cancer Programs and Community Outreach
The city of St. Paul, Minnesota, recently served as the backdrop for a significant philanthropic...
Dr. Moghimi & team has tool to treat Acute Myeloid leukemia
Children’s Hospital Los Angeles (CHLA) has announced a significant advancement in the fight against pediatric...
U.S. FDA Grants Accelerated Approval to Tudriqev, Marking First New Oncolytic Virus Therapy in Over a Decade for Advanced Melanoma
The U.S. Food and Drug Administration (FDA) has announced the accelerated approval of Tudriqev (vusolimogene...
Scholar Rock SMA drug approved by FDA
The U.S. Food and Drug Administration (FDA) has granted approval for apitegromab, to be marketed...
